In vitro activity of tebipenem and comparator agents against bacterial pathogens isolated from patients with cancer
Bahgat Gerges, Joel Rosenblatt, Samuel A Shellburne, Anne-Marie Chaftari, Ray Hachem, Issam Raad · 2023
Read In vitro activity of tebipenem and comparator agents against bacterial pathogens isolated from patients with cancer by Bahgat Gerges, Joel Rosenblatt, Samuel A Shellburne, Anne-Marie Chaftari, Ray Hachem, Issam Raad (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10712722.txt.
Description
Bahgat Gerges and co-authors tested in 2023 a mouth-taken antibiotic against germs taken from patients with cancer. The drug covers a wide range of germs and could replace drip-fed drugs of the same family. A total of 611 germ samples from cancer patients were tested against it and rival drugs.
Standard lab dilution methods set the lowest drug level that stops each germ. For most germ types, that level for the new drug was low. For gut-type germs, the level that stopped ninety percent of samples sat in a narrow low range. The authors call the oral drug promising for cancer patients and urge patient trials.
Catalog record
| CREATOR | Bahgat Gerges, Joel Rosenblatt, Samuel A Shellburne, Anne-Marie Chaftari, Ray Hachem, Issam Raad |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |